Open AccessTedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease
Author(s) -
Devyani Deshpande,
Shashikant Srivastava,
Jotam G. Pasipanodya,
Pooi S Lee,
Tawanda Gumbo
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx305
Subject(s) - pharmacokinetics , mycobacterium avium complex , antibiotics , minimum inhibitory concentration , pharmacodynamics , medicine , pulmonary disease , pharmacology , microbiology and biotechnology , biology
To determine if tedizolid is effective for pulmonary Mycobacterium avium complex (MAC) disease, and to use pharmacokinetics/pharmacodynamics to design optimal doses.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom